GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Yousif Capital Management LLC

Yousif Capital Management LLC increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.4% during the 4th quarter, Holdings Channel reports. The fund owned 68,958 shares of the company’s stock after purchasing an additional 4,768 shares during the quarter. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $5,391,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Sargent Investment Group LLC grew its stake in shares of GE HealthCare Technologies by 5.8% during the 4th quarter. Sargent Investment Group LLC now owns 3,914 shares of the company’s stock worth $334,000 after purchasing an additional 215 shares during the period. E. Ohman J or Asset Management AB boosted its holdings in GE HealthCare Technologies by 10.9% during the fourth quarter. E. Ohman J or Asset Management AB now owns 20,300 shares of the company’s stock worth $1,587,000 after buying an additional 2,000 shares in the last quarter. Mather Group LLC. increased its holdings in GE HealthCare Technologies by 14.3% in the fourth quarter. Mather Group LLC. now owns 1,977 shares of the company’s stock valued at $155,000 after buying an additional 247 shares in the last quarter. Brown Lisle Cummings Inc. raised its position in shares of GE HealthCare Technologies by 33.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 605 shares of the company’s stock worth $47,000 after acquiring an additional 150 shares during the period. Finally, Tandem Capital Management Corp ADV boosted its stake in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after acquiring an additional 118 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on GEHC shares. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $88.55 on Friday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a 50-day moving average price of $83.25 and a 200 day moving average price of $85.17. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.55. The stock has a market cap of $40.46 billion, a P/E ratio of 24.33, a PEG ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.